Brain Metastases
📧 Sign up to get email alerts when something new happens for Brain Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis [Phase 2]
Phase 2 clinical trial examining a triple-drug regimen (adebrelimab, apatinib, and etoposide) for HER2-negative breast cancer with brain met…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: A Retrospective Study of Prognostic Factors and Survival of Breast Cancer Patients With Brain Metastesis
This retrospective study analyzes prognostic factors and survival in patients with breast cancer who have brain metastases.
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer. [NA]
The document reports a clinical trial evaluating tumor treating fields in combination with stereotactic radiosurgery for brain metastases fr…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases [Phase 2]
Phase 2 clinical trial evaluating cadonilimab in combination with stereotactic radiotherapy as a second-line treatment for brain metastases …
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Negative Driver Genes (IVO BRAIN) [Phase 2]
A multicenter, single-arm Phase 2 trial evaluating AK112 in combination with chemotherapy as first-line treatment for patients with non-squa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases
An ongoing study from Fudan University evaluating AI-guided prognostication and cranial radiotherapy optimization in EGFR-TKI–treated patien…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of tumor-infiltrating lymphocyte (TIL) therapy with pembrolizumab for advanced brai…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC [Phase 2]
A Phase 2 study is evaluating osimertinib plus stereotactic radiosurgery (SRS) versus osimertinib alone in patients with EGFR-positive non-s…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases [NA]
This clinical trial update describes a study evaluating stereotactic radiation for patients with small cell lung cancer and 1–10 brain metas…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial [NA]
A Phase III randomized trial comparing hippocampal-sparing whole-brain radiation versus stereotactic radiation in patients with 5-20 brain m…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases [Phase 2]
Phase 2 clinical trial evaluating antirotiinib hydrochloride in combination with whole brain radiotherapy for small cell lung cancer with br…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy. [NA]
BEAT-Breast is a clinical trial evaluating DE-iPTV for breast cancer with brain metastases in patients unsuitable for stereotactic radiother…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy [EARLY_Phase 1]
A phase 1 study from Vanderbilt-Ingram Cancer Center is evaluating image-based, in-vivo assessment of tumor hypoxia to guide hypoxia-driven …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC [Phase 2]
A single-arm, prospective Phase II trial assessing Utidelone plus capecitabine for active brain metastases in triple-negative metastatic bre…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors [Phase 2]
Phase 2 trial comparing low-dose versus standard-dose dexamethasone to reduce swelling in patients with malignant brain neoplasms and brain …
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis [Phase 2]
A Phase 2 clinical trial from Fudan University evaluates cranial radiotherapy combined with chemoimmunotherapy for untreated driver-mutation…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis [Phase 2]
A Phase 2 clinical trial update on cranial radiotherapy combined with chemoimmunotherapy for untreated driver-mutation negative non-small ce…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Stereotactic Radiotherapy Management of Brain Metastases: the Value of a Longitudinal Multimodal Approach (POSTPONE)
This clinical trial update outlines a study on stereotactic radiotherapy management of brain metastases using a longitudinal multimodal appr…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: A Phase II Study of Triple-negative Breast Cancer Brain Metastases. [Phase 2]
A Phase II clinical trial evaluating treatment for brain metastases in patients with triple-negative breast cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Pre-operative Stereotactic Radiosurgery Followed by Resection for Patients With Brain Metastases [NA]
This clinical trial update notes that a study evaluating pre-operative stereotactic radiosurgery followed by surgical resection for brain me…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)
METABREC (NCT04654975) is a clinical trial investigating brain metastases after esophagectomy for esophageal cancer. The study is currently …
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases
This clinical trial entry reports recruiting status for a study on local ablative therapy for patients with multiple brain metastases (4-10 …
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer [NA]
This clinical trial is evaluating the combination of stereotactic radiotherapy (SRT) with anlotinib for brain metastases from non-small cell…
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases [Phase 2]
A Phase 2 trial at UCSD is evaluating image-guided, cognitive-sparing radiosurgery for brain metastases. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases [Phase 2]
A Phase 2 clinical trial evaluating sacituzumab govitecan combined with brain radiotherapy for HER2-negative breast cancer with brain metast…